Document is current
Any future updates will be listed below
-
Authors
Cabaleiro, T
Prieto-Pérez, R
Navarro, R
Solano, G
Román, M
Ochoa, D
Abad-Santos, F
Daudén, E
- License Information
-
More Information
Article History
Received: 11 March 2015
Revised: 26 May 2015
Accepted: 3 June 2015
First Online: 21 July 2015
Competing interests
: E Daudén has conflict of interest (advisory board member, consultant, grants, research support, participation in clinical trials, honoraria for speaking and research support) with the following pharmaceutical companies: AbbVie (Abbott), Amgen, Janssen-Cilag, Leo Pharma, Novartis, Pfizer, MSD and Celgene. F Abad-Santos and D Ochoa have been consultants or investigators in clinical trials sponsored by the following pharmaceutical companies: Abbott, Alter, Chemo, Faes, Farmalíder, Ferrer, GlaxoSmithKline, Janssen-Cilag, Kern, Normon, Servier, Teva and Zambon. The remaining authors declare no conflict of interest.
